Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Novo Holdings A/S
Form 13F · Q2 2026

Novo Holdings A/S

CIK 1388325Filed 2026-08-1413F-HR View the filing on EDGAR ↗
$1.7B
Reported book value
25
Positions
12
Quarters on record
Top 50
Positions

Novo Holdings A/S — holdings

Top 25 positions of 25, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1EWTX Edgewise Therapeutics Inc5.3M+0.0%$217M12.6%
2ASML Asml Hldg Nv94,946+0.0%$189M11.0%
3COAG Hemab Therapeutics Hldgs Inc4.2M—$154M8.9%
4BN Brookfield Corp3.5M+0.0%$150M8.7%
5MPLT Maplight Therapeutics Inc3.7M+0.0%$132M7.7%
6MIRM Mirum Pharmaceuticals Inc1.1M−15.1%$132M7.6%
7AVLN Avalyn Pharmaceuticals Inc3.9M—$128M7.4%
8CRM Salesforce Inc393,187+0.0%$62M3.6%
9AVBP Arrivent Biopharma Inc1.5M−22.8%$52M3.0%
10ELVN Enliven Therapeutics Inc1.0M−21.9%$51M2.9%
11CRINETICS PHARMACEUTICALS IN Crinetics Pharmaceuticals In1.3M−14.8%$49M2.9%
12PHVS Pharvaris N V1.4M−20.0%$48M2.8%
13FND Floor & Decor Hldgs Inc797,000—$47M2.7%
14PCVX Vaxcyte Inc800,000−7.0%$47M2.7%
15FDMT 4D Molecular Therapeutics In3.2M−11.0%$43M2.5%
16VRDN Viridian Therapeutics Inc2.1M+6.8%$39M2.3%
17CLDX Celldex Therapeutics Inc New1.0M−14.6%$38M2.2%
18ALMS Alumis Inc1.1M—$31M1.8%
19XENE Xenon Pharmaceuticals Inc485,438+0.0%$29M1.7%
20BABA Alibaba Group Hldg Ltd257,327+0.0%$25M1.4%
21DYN Dyne Therapeutics Inc960,394—$21M1.2%
22BBOT Bridgebio Oncology Therapeut2.2M+2.9%$17M1.0%
23INSM Insmed Inc120,723—$13M0.7%
24MQ Marqeta Inc441,558+0.0%$7M0.4%
25LNZA Lanzatech Global Inc158,148+0.0%$1M0.1%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.